Fundz

Zimmer

Warsaw, Indiana, United States · Artificial Intelligence, Biotechnology, Health Care

Zimmer, Inc. is a subsidiary of Zimmer Biomet Holdings, Inc., specializing in orthopedic reconstructive products and related services. The company focuses on providing solutions for musculoskeletal health and enhancing patient care. With a commitment to innovation, Zimmer, Inc. delivers advanced surgical tools and devices.

Key facts

Headquarters
Warsaw, Indiana, United States
Employees
17,000
Industries
Artificial Intelligence, Biotechnology, Health Care
Status
Public (ZBH)
Website
zimmerbiomet.com
LinkedIn
Company page

Recent activity at Zimmer

  • : Zimmer Biomet Announces Executive Departure of Kevin Thornal
  • : Zimmer Biomet Promotes Gary Campbell, Brian Hatcher, and Bradley Kessler
  • : Zimmer Biomet to acquire Iovera for $140M
  • : Zimmer Biomet Appoints Paul Stellato as Interim Chief Financial Officer
  • : SEC 8-K (5.02): On September 8, 2026, Zimmer Biomet Holdings, Inc. announced the restructuring of the position held by Kevin Thornal, Group President, Global Businesses and the Americas. As a result of this restructuring, Mr. Thornal will be departing from the company, with his effective departure date set for September 30, 2026. He will qualify for severance benefits under the company's Restated Executive Severance Plan. This change may signal a shift in the company's management structure and strategic direction, impacting its operational leadership and future business initiatives.
  • : SEC 8-K (8.01):
  • : SEC 8-K (1.01): On June 26, 2026, Zimmer Biomet Holdings, Inc. entered into a new five-year revolving credit agreement worth $1.5 billion and a new 364-day revolving credit agreement worth $1.25 billion with JPMorgan Chase Bank, N.A. The five-year credit facility matures on June 26, 2031, with the option for two one-year extensions, while the 364-day facility matures on June 25, 2027. The funds will be used for general corporate purposes, with interest rates tied to the adjusted Term SOFR or an alternate base rate plus an applicable margin based on the company’s credit rating. The agreements impose certain financial covenants, including a maximum consolidated indebtedness to consolidated EBITDA ratio of 4.5 to 1.0, with potential adjustments for acquisitions.
  • : SEC 8-K (7.01): On May 12, 2026, Zimmer Biomet Holdings, Inc. announced its intention to repurchase up to $1.0 billion of its shares during fiscal year 2026, which is under the existing $1.5 billion share repurchase authorization approved by the Board of Directors in February 2026. This share repurchase plan signifies an adjustment to the Company's previously disclosed capital allocation strategy for the year 2026. The announcement was made public via a press release contemporaneously issued by the Company, indicating a proactive approach towards enhancing shareholder value. It reflects the Company’s confidence in its financial position and growth prospects amidst market conditions.
  • : SEC 8-K (5.02):
  • : SEC 8-K (5.02):

Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.

Leadership

  • Kevin Thornal, President
  • Brian Hatcher, President
  • Gary Campbell, President
  • Paul Stellato, Chief Financial Officer
  • Ivan Tornos, President
  • David DeMartino, Vice President of Investor Relations
  • Shaun Braun, Chief Information Officer

Verified email and direct lines for Zimmer’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.

Employee benefit plans

Zimmer files 24 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.

Zimmer in the news

Companies similar to Zimmer

  • Esaote Group · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Medical, Medical Device, medical devices
  • Edwards Lifesciences · Artificial Intelligence, Biotechnology, Health Care, Manufacturing, Medical, Medical Device
  • Mindray · Biotechnology, Health Care, Manufacturing, Medical, Medical Device, medical devices
  • Solventum · Biotechnology, Health Care, Manufacturing, Medical, Medical Device
  • Elsevier · Artificial Intelligence, Biotechnology, Health Care, Information Technology, Medical

About Zimmer: questions and answers

What does Zimmer do?

Zimmer, Inc. is a subsidiary of Zimmer Biomet Holdings, Inc., specializing in orthopedic reconstructive products and related services. The company focuses on providing solutions for musculoskeletal health and enhancing patient care. With a commitment to innovation, Zimmer, Inc. delivers advanced surgical tools and devices.

Where is Zimmer headquartered?

Zimmer is headquartered in Warsaw, Indiana, United States.

How many employees does Zimmer have?

Zimmer has about 17,000 employees.

Who leads Zimmer?

Kevin Thornal is a President at Zimmer.

What is the latest news on Zimmer?

On Sep 8, 2026, Zimmer Biomet Announces Executive Departure of Kevin Thornal

Is Zimmer a public company?

Yes. Zimmer is publicly traded under the ticker ZBH.

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Zimmer across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.